Global Single-Cell Genome Sequencing Market was valued US$ 1.20 Bn in 2019 and is expected to reach US$ 3.50 Bn by 2027, at a CAGR of 14.32 % during a forecast period.

The report has analyzed revenue impact of the COVID-19 pandemic on the sales revenue of the market leader, market followers and market disrupters in the report and same is reflected in our analysis.

To know about the Research Methodology :- Request Free Sample Report

The Single-cell sequencing has emerged as an innovative method, which reveals biological process with unprecedented resolution and scale. It is also an effective approach to characterize organisms, which are difficult to culture in vitro.
Global Single-Cell Genome Sequencing Market, Dynamics:

Advancements in single-cell sequencing have improved the detection method and analysis of infectious diseases, food-borne pathogens, and microbial diversities. Development in the field of single-cell genome sequencing offers a window into the extent and nature of transcriptomic heterogeneity and genomic, which are expected to propel the growth of the single-cell genome sequencing market.

The single-cell genomics allows for insight into the heterogeneity of tissues and organs in normal development and function. It also enables the study of disease processes in specific cell types. The one of the latest trends in single-cell genomics market has witnessed a combination of multiple molecular readouts from thousands of single cells. The application of single-cell combinatorial indexing has permitted for simultaneous analysis of the open chromatin and RNA profiles of individual cells. On the other hand, high cost, and analytical challenges in measurement of the single molecule of DNA are expected to limit the growth of the global single-cell genome sequencing market.
Global Single-Cell Genome Sequencing Market, Segment Analysis:

The cancer is one of leading non-communicable disease. According to World Health Organization, it is the second leading cause of death. According to a report by International Age for Research on Cancer in 2019, more than 18 million new cases of cancer were registered with around 9 million death and more than 35 million people are living with cancer worldwide. The cancer segment is expected to grow at xx% rate of CAGR during the forecast period. An Introduction of new therapies for the treatment of cancer like personalized medicine (Immuno-oncology and others) is expected to increase the adaption of single cell genomic sequencing for evolving research to observe cellular level changes in cancer cells.

NGS platform is expected to contribute xx% share in the global single-cell genome sequencing market. With an introduction of next-generation sequencing, high-throughput measurements of biomolecules in tissues especially RNA and DNA have developed rapidly across the globe. The NGS platform permits parallel sequencing of multiple targeted genomic regions in many samples to detect concomitant mutations. It can deal with maximal tumor genomic assessment. The development of next-generation sequencing (NGS) technologies has provided many valuable insights into complex biological systems, which are ranging from cancer genomics to diverse microbial communities. The adoption of NGS-based technologies for genomics, transcriptomics, and epigenomics are now increasingly focused on the characterization of individual cells, which allow researchers to uncover new and potentially unexpected biological discoveries.
Global Single-Cell Genome Sequencing Market, Regional Analysis:

North America is expected to contribute xx% share in global single-cell genome sequencing market during the forecast period. The growth in the market is attributed to the rise in single cell research funding along with continuous establishment of Single Cell Genome sequencing (SCG) centers and presence of many key players across the region. High adoption of advancing Tools and Technologies are expected to boost the market growth. In addition, increasing investigations in genomics are expected to drive the growth of the market. For instance, Researchers at the University of California has conducted the study of microfluidic droplet barcoding at ultra-high-throughput analyzed distributions of phage sequences, antibiotic resistance genes, and virulence factors.

Currently, single-cell genome sequencing market key players are forming partnerships with other key players to enhance their product portfolios. Key Players are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge across the globe. For instance, in 2018, Illumina has launched semiconductor-based sequencing system iSeq 100t, which uses sequencing-by-synthesis chemistry with CMOS detection technology.
Global Single-Cell Genome Sequencing Market, Competitive Analysis:

Technological advancements in the field of single-cell genome sequencing are playing an instrumental role in the development of the single-cell genome sequencing market. Many market key players are focusing on the collaboration to expand their global footprint. For instance, Bio-Rad Laboratories, Inc. and Illumina, Inc has collaborated to develop an innovative workflow for single-cell genome sequencing analysis. The technologically innovative platforms offer intuitive analysis software solutions. Growing focus of Key players on product development are triggering market growth. Moreover, supportive government policies are expected to boost the market growth during the forecast period.

The objective of the report is to present a comprehensive analysis of the Global Single-Cell Genome Sequencing Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Single-Cell Genome Sequencing Market dynamics, structure by analyzing the market segments and projects the Global Single-Cell Genome Sequencing Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Single-Cell Genome Sequencing Market make the report investor’s guide.
Scope of the Global Single-Cell Genome Sequencing Market: Inquire before buying

Global Single-Cell Genome Sequencing Market, By Product Type

• Instruments
• Reagents
Global Single-Cell Genome Sequencing Market, By Technology

• NGS
• PCR
• qPCR
• Microarray
• MDA
Global Single-Cell Genome Sequencing Market, By Workflow

• Single-cell isolation
• Sample preparation
• Genomic analysis
Global Single-Cell Genome Sequencing Market, By End User

• Academic & research laboratories
• Biotechnology & biopharmaceutical companies
• Clinics
• Others
Global Single-Cell Genome Sequencing Market, By Disease Area

• Cancer
• Immunology
• Prenatal diagnosis
• Neurobiology
• Microbiology
• Others
Global Single-Cell Genome Sequencing Market, By Region

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• South America
Key players operating in Global Single-Cell Genome Sequencing Market

• Fludigim
• QIAGEN
• Illumina
• F Hoffmann-La Roche Ltd.
• ThermoFisher Scientific, Inc.
• Bio-Rad
• 10X Genomics, Inc.
• BD
• Oxford Nanopore Technologies
• BGI
• Pacific Biosciences Inc.
• DNA Electronics Ltd.
• Agilent Technologies Inc
• NuGEN Technologies, Inc.
• Novogene Co. Ltd.
• Takara Bio, Inc.

For More Information Visit @:https://www.maximizemarketresearch.com/market-report/global-single-...

This Report Is Submitted By : Maximize Market Research Company

Customization of the report:          

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research: 

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.